Thinking on risk assessment and risk management of post-marketing Chinese medicine.
- Author:
Xueqing YU
1
;
Yanming XIE
;
Yongyan WANG
Author Information
1. Institute of Clinical Basic Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. yxqshi@126.com
- Publication Type:Journal Article
- MeSH:
Adverse Drug Reaction Reporting Systems;
Drug-Related Side Effects and Adverse Reactions;
etiology;
prevention & control;
Humans;
Medicine, Chinese Traditional;
adverse effects;
Product Surveillance, Postmarketing;
methods;
Risk Assessment;
methods;
Risk Factors
- From:
China Journal of Chinese Materia Medica
2012;37(2):262-264
- CountryChina
- Language:Chinese
-
Abstract:
Drug risk assessment and management is an important measure for reducing the adverse drug reaction and enhancing medication safety of the patient. Based on the concepts of drug risk assessment and risk management, and domestic and international drug risk management situation, this paper discusses the risk management of post-marketing Chinese medicine.
